Latest filing published 27 Feb 2025 for Sanara MedTech Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Ronald T. Nixon across 2 companies, led by Sanara MedTech Inc. and LHC Group, Inc. In total, 24 filings cover trades dated from 1 March 2016 to 25 February 2025.
On the open market, the record shows 1 purchase worth €7.2M and 2 sales worth €2.1M. Purchases outweigh sales by €5.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 17 share grants.
The latest filing, published on 27 February 2025, reports a share grant in Sanara MedTech Inc. The last purchase on record was published on 17 October 2019, which is 2,563 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations